Expert System for Automatic Analysis of Data Quality in Clinical Trials
In the framework of the development scheme 'Central Innovation Scheme for Medium-sized Businesses' of the German Federal Ministry for Economics and Technology (BMWI), clinIT AG, based in Freiburg, Germany, has been awarded a six-figure federal grant in cooperation with the Institute for Informatics of the Albert-Ludwigs-University Freiburg, Faculty for Data Bases and Information Systems.
Read more ...
Strengthening pharmacovigilance to reduce adverse effects of medicines
Medicinal products contribute considerably to the health of EU citizens. They can, however, also have adverse effects. It is estimated that 5% of all hospital admissions are due to an adverse drug reaction (ADR), and that ADR is the fifth most common cause of hospital death.
Read more ...
Innovators from Global Biopharma Companies Discuss Consumer & Physician E-marketing Trends
In recent years European healthcare consumers and physicians have steadily increased their use of the Internet for treatment and product decisions. According to healthcare and pharmaceutical market research company's Manhattan Research's Cybercitizen Health™ Europe v8.0 study and strategy advisory service, over 150 million adults in countries across Europe used online channels to access health information in 2008.
Read more ...
New discovery: lethal fungus reproduces sexually
Researchers in Ireland and the UK have found that a lethal fungus, Aspergillus fumigatus, reproduces sexually. The findings represent a major breakthrough in the understanding of this pathogen, which causes death in 50% of infected immune-deficient patients.
Read more ...
New mouse model for study of Creutzfeldt-Jakob disease
Italian researchers have bred mice that exhibit similar deficits to those experienced by people with Creutzfeldt-Jakob disease, a prion disease similar to bovine spongiform encephalopathy. The EU-funded study, published in the journal Neuron, provides insights that may help to diagnose prion diseases early, when therapeutic intervention may be effective.
Read more ...
UK's Government and Industry in drug price deal
A new deal has been reached between the UK's Government and the pharmaceutical industry means that more patients will benefit from a wider range of innovative drug treatments at a fair price to the NHS. The flexible pricing scheme agreed will ensure that medicines fairly reflect their value to patients, branded drugs will see their price cut, and industry innovations will be encouraged and rewarded.
Read more ...
Manhattan Research Releases Report on the Future of Physician Customer Service Portals
Over the past year, physician visitation to customer service portals decreased while interest in using them actually increased. To help biopharma companies bridge the gap between the current portal landscape and unmet physician demand, pharmaceutical and healthcare market research company Manhattan Research just released its latest physician module report, "The Case for Customer Care: Service Portals and a Successfully Integrated CRM System" as part of its ePharma Physicianâ v8.0 market research and strategic advisory service.
Read more ...
Medicinal products contribute considerably to the health of EU citizens. They can, however, also have adverse effects. It is estimated that 5% of all hospital admissions are due to an adverse drug reaction (ADR), and that ADR is the fifth most common cause of hospital death. 
In recent years European healthcare consumers and physicians have steadily increased their use of the Internet for treatment and product decisions. According to healthcare and pharmaceutical market research company's Manhattan Research's Cybercitizen Health™ Europe v8.0 study and strategy advisory service, over 150 million adults in countries across Europe used online channels to access health information in 2008. 